AKERO THERAPEUTICS INC (AKRO)
US00973Y1082 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 234.21M | 249.80M | 150.50M | 187.20M | 64.80M | |||
| Marketable Securities | 315.80M | 101.70M | 37.80M | 81.10M | 71.60M | |||
| Other Current Assets | 9.95M | 3.70M | 5.30M | 3.00M | 1.60M | |||
| Total Current Assets | 559.96M | 355.20M | 193.60M | 271.30M | 138.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.03M | 1.30M | 1.50M | 1.80M | N/A | |||
| Investments And Advances | 19.28M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 100.00K | 400.00K | 200.00K | 100.00K | |||
| Total Non-Current Assets | 20.31M | 1.40M | 1.90M | 2.00M | 100.00K | |||
| TOTAL ASSETS | 580.27M | 356.60M | 195.50M | 273.30M | 138.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.09M | 11.10M | 18.40M | 9.70M | 8.30M | |||
| Accounts Payable | 7.04M | 8.00M | 6.70M | 3.40M | 900.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 100.00K | |||
| Total Current Liabilities | 19.13M | 19.10M | 25.10M | 13.10M | 9.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 24.96M | 9.50M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 873.00K | 1.40M | 1.30M | 1.50M | 0.00 | |||
| Total Non-Current Liabilities | 25.84M | 10.90M | 1.30M | 1.50M | 0.00 | |||
| TOTAL LIABILITIES | 44.97M | 30.00M | 26.40M | 14.60M | 9.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -574.10M | -422.30M | -310.30M | -209.50M | -130.30M | |||
| Additional Paid In Capital | 1.11B | 748.90M | 479.40M | 468.20M | 259.00M | |||
| Common Shares | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 270.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 55.75M | 46.90M | 34.90M | 34.70M | 28.60M | |||
| Tangible Book Value per Share | 9.60 | 6.96 | 4.85 | 7.46 | 4.50 | |||
| Total Shareholders' Equity | 535.31M | 326.60M | 169.10M | 258.70M | 128.70M | |||
| TOTAL LIABILITIES AND EQUITY | 580.27M | 356.60M | 195.50M | 273.30M | 138.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.03 | N/A | N/A | N/A | |||
| Current Ratio | 29.27 | 18.60 | 7.71 | 20.71 | 14.68 | |||
| Return On Assets (ROA) | -26.15% | -31.42% | -51.55% | -28.98% | -31.69% | |||
| Return On Equity (ROE) | -28.35% | -34.30% | -59.60% | -30.62% | -34.00% | |||
All data in USD